Toggle light / dark theme

The Future of Human Cloning

In 1996, the first mammal cloned from an adult somatic cell was born. Named Dolly after the famous singer Dolly Parton, this sheep made headlines around the world when it was announced the following year, by demonstrating that a cloned organism could be produced from a mature cell from a specific body part, in this case, a mammary gland. Since Dolly, many other mammals including goats, rabbits, cats, and primates have been cloned. However, nearly 30 years later, no human clones have even been attempted. Today, we will discuss why, and what the future holds for human cloning.

Human cloning has been a fixture of science fiction for decades, as early as Aldous Huxley’s 1932 novel Brave New World. However, despite its popularity in film, television, and video games, it’s not been popular at all with lawmakers. As of 2018, around 70 nations have outright banned human cloning. In the United States, despite there not being a federal ban on it, 15 states ban reproductive cloning, and 10 states prevent cloned human embryos to be implanted for childbirth.

Over the years, there have been several people who claimed to have successfully cloned humans. One of the most infamous was from a religious group called the Raëlians, who have a core belief that human beings were created by extraterrestrials thousands of years ago using advanced technology. Soon after the unveiling of Dolly, the Raëlians established Clonaid, to fund the research and development of human cloning. After moving their base of operations from the US to the Bahamas, on the 26th of December, 2002, a team led by French chemist Brigitte Boisselier announced that the first successfully cloned human, named Eve, had been born a day before.

Hevolution Foundation announces new awards in aging biology and geroscience research

Hevolution Foundation, a non-profit organisation that provides grants and early-stage investments to incentivise research and entrepreneurship in healthspan science, and the American Federation for Aging Research (AFAR) have today announced an international research grant programme to enable early-career investigators to conduct research into healthspan-expanding therapeutics and treatments.

Longevity. Technology: Founded in the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, the Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development and increase accessibility to therapeutics that extend healthspan.

A non-profit organisation headquartered in Riyadh, with an annual budget of up to $1 billion, Hevolution Foundation plans to open hubs in North America and other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer.

/* */